The ethanol extract of the inner bark of Caesalpinia pyramidalis (Tul.) reduces urinary bladder damage during cyclophosphamide-induced cystitis in rats

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Moraes, Janaína P ^a   Pereira, Denyson S ^a   Matos, Alexandre S ^a   Santana, Danielle G ^a   Santos, Cliomar A ^a   Estevam, Charles S ^a   Fakhouri, Ricardo ^a   De Lucca Junior, Waldecy ^a   Camargo, Enilton A ^a  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CAESALPINIA PYRAMIDALIS PLANT EXTRACT; CYCLOPHOSPHAMIDE; MALONALDEHYDE; MESNA; MYELOPEROXIDASE; NITRATE; NITRIC OXIDE; NITRITE; PLANT EXTRACT; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; ARTICLE; BARK; BLADDER; BLADDER EDEMA; CAESALPINIA; CAESALPINIA PYRAMIDALIS; CONTROLLED STUDY; EDEMA; ENZYME ACTIVITY; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; LUNG; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SPLEEN; TISSUE HOMOGENATE; ANIMAL; BLEEDING; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYSTITIS; DISEASE MODEL; DRUG EFFECT; ENZYME ACTIVATION; LEUKOCYTE COUNT; LIPID PEROXIDATION; METABOLISM; PATHOLOGY;

ANIMALIA; CAESALPINIA PYRAMIDALIS; RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CAESALPINIA; CYCLOPHOSPHAMIDE; CYSTITIS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; HEMORRHAGE; LEUKOCYTE COUNT; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE; PEROXIDASE; PLANT BARK; PLANT EXTRACTS; RATS; URINARY BLADDER;

EID: 84890071457     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/694010     Document Type: Article

References (29)

1. Ratliff T. R., Williams R. D., Hemorrhagic cystitis, chemotherapy, and bladder toxicity. The Journal of Urology 1998 159 3 1044 2-s2.0-0032013491
2. Korkmaz A., Topal T., Oter S., Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biology and Toxicology 2007 23 5 303 312 2-s2.0-34250335972 10.1007/s10565-006-0078-0 (Pubitemid 46919119)
3. Perini P., Calabrese M., Rinaldi L., Gallo P., Cyclophosphamide-based combination therapies for autoimmunity. Neurological Sciences 2008 29 2 S233 S234 2-s2.0-53649098912 10.1007/s10072-008-0947-9
4. Mukhtar S., Woodhouse C., The management of cyclophosphamide-induced haematuria. BJU International 2010 105 7 908 912 2-s2.0-77749255514 10.1111/j.1464-410X.2009.09132.x
5. Zhang J., Tian Q., Sui Y. C., Shu C. L., Zhou S., Duan W., Zhu Y.-Z., Metabolism and transport of oxazaphosphorines and the clinical implications. Drug Metabolism Reviews 2005 37 4 611 703 2-s2.0-30444441659 10.1080/03602530500364023 (Pubitemid 43071142)
6. Kehrer J. P., Biswal S. S., The molecular effects of acrolein. Toxicological Sciences 2000 57 1 6 15 2-s2.0-0033864802
7. Morais M. M., Belarmino-Filho J. N., Brito G. A. C., Ribeiro R. A., Pharmacological and histopathological study of cyclophosphamide-induced hemorrhagic cystitis-comparison of the effects of dexamethasone and Mesna. Brazilian Journal of Medical and Biological Research 1999 32 10 1211 1215 2-s2.0-0032749411
8. Macedo F. Y. B., Baltazar F., Almeida P. R. C., Távora F., Ferreira F. V., Schmitt F. C., Brito G. A. C., Ribeiro R. A., Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats. Journal of Cancer Research and Clinical Oncology 2008 134 1 19 27 2-s2.0-35948968829 10.1007/s00432-007-0237-6 (Pubitemid 350064247)
9. Abraham P., Rabi S., Protein nitration, PARP activation and NAD+ depletion may play a critical role in the pathogenesis of cyclophosphamide- induced hemorrhagic cystitis in the rat. Cancer Chemotherapy and Pharmacology 2009 64 2 279 285 2-s2.0-67349163258 10.1007/s00280-008-0868-6
10. Abraham P., Rabi S., Kulothungan P., Aminoguanidine, selective nitric oxide synthase inhibitor, ameliorates cyclophosphamide-induced hemorrhagic cystitis by inhibiting protein nitration and PARS activation. Urology 2009 73 6 1402 1406 2-s2.0-67349143625 10.1016/j.urology.2008.10.039
11. Boeira V. T., Leite C. E., Santos A. A. Jr., Edelweiss M. I., Calixto J. B., Campos M. M., Morrone F. B., Effects of the hydroalcoholic extract of Phyllanthus niruri and its isolated compounds on cyclophosphamide-induced hemorrhagic cystitis in mouse. Naunyn-Schmiedeberg's Archives of Pharmacology 2011 384 3 265 275 2-s2.0-80054922549 10.1007/s00210-011-0668-0
12. Hamsa T. P., Kuttan G., Protective role of Ipomoea obscura (L.) on cyclophosphamide-induced uro- and nephrotoxicities by modulating antioxidant status and pro-inflammatory cytokine levels. Inflammopharmacology 2011 19 3 155 167 2-s2.0-80755175634
13. Rezvanfar M. A., Farshid A. A., Sadrkhanlou R. A., Ahmadi A., Rezvanfar M. A., Salehnia A., Abdollahi M., Benefit of Satureja khuzestanica in subchronically rat model of cyclophosphamide-induced hemorrhagic cystitis. Experimental and Toxicologic Pathology 2010 62 3 323 330 2-s2.0-77952891462 10.1016/j.etp.2009.05.005
14. De Fátima Agra M., De Freitas P. F., Barbosa-Filho J. M., Synopsis of the plants known as medicinal and poisonous in Northeast of Brazil. Brazilian Journal of Pharmacognosy 2007 17 1 114 140 2-s2.0-34047187912
15. Santos C. A., Passos A. M. P. R., Andrade F. C., Camargo E. A., Estevam C. S., Santos M. R. V., Thomazzi S. M., Antinociceptive and anti-inflammatory effects of Caesalpinia pyramidalis in Rodents. Brazilian Journal of Pharmacognosy 2011 21 6 1077 1083 2-s2.0-80054855023 10.1590/S0102- 695X2011005000179
16. Santana D. G., Santos C. A., Santos A. D., Beneficial effects of the ethanol extract of Caesalpinia pyramidalis on the inflammatory response and abdominal hyperalgesia in rats with acute pancreatitis. Journal of Ethnopharmacology 2012 142 445 455
17. Kiuchi H., Takao T., Yamamoto K., Nakayama J., Miyagawa Y., Tsujimura A., Nonomura N., Okuyama A., Sesquiterpene lactone parthenolide ameliorates bladder inflammation and bladder overactivity in cyclophosphamide induced rat cystitis model by inhibiting nuclear factor-kappaB phosphorylation. Journal of Urology 2009 181 5 2339 2348 2-s2.0-64049091647 10.1016/j.juro.2009.01.015
18. Pereira D. S., Morais J. P., Santana D. G., Effects of the ethanol extract of the inner bark of Syderoxylum obtusifolium in the cyclophosphamide-induced cystitis in rats. Journal of Medicinal Plants Research 2013 7 1411 1417
19. Bradley P. P., Priebat D. A., Christensen R. D., Rothstein G., Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. Journal of Investigative Dermatology 1982 78 3 206 209 2-s2.0-0020051148 (Pubitemid 12171880)
20. Bose R., Sutherland G. R., Pinsky C., Biological and methodological implications of prostaglandin involvement in mouse brain lipid peroxidation measurements. Neurochemical Research 1989 14 3 217 220 2-s2.0-0024514969 (Pubitemid 19132449)
21. Kanat O., Kurt E., Yalcinkaya U., Evrensel T., Manavoglu O., Comparison of uroprotective efficacy of mesna and amifostine in cyclophosphamide- induced hemorrhagic cystitis in rats. Indian Journal of Cancer 2006 43 1 12 15 2-s2.0-33745121518 (Pubitemid 43900536)
22. Bhatia K., Ahmad F., Rashid H., Raisuddin S., Protective effect of S-allylcysteine against cyclophosphamide-induced bladder hemorrhagic cystitis in mice. Food and Chemical Toxicology 2008 46 11 3368 3374 2-s2.0-54449098874 10.1016/j.fct.2008.08.011
23. Al-Yahya A. A., Al-Majed A. A., Gado A. M., Daba M. H., Al-Shabanah O. A., El-Azab A. S., Abd-Allah A. R. A., Acacia senegal gum exudate offers protection against cyclophosphamide- induced urinary bladder cytotoxicity. Oxidative Medicine and Cellular Longevity 2009 2 4 207 213 2-s2.0-77953468282 10.4161/oxim.2.4.8878
24. Abraham P., Isaac B., Ramamoorthy H., Natarajan K., Oral glutamine attenuates cyclophosphamide-induced oxidative stress in the bladder but does not prevent hemorrhagic cystitis in rats. Journal of Medical Toxicology 2011 7 2 118 124 2-s2.0-79959323629 10.1007/s13181-010-0103-9
25. Patel J. M., Metabolism and pulmonary toxicity of cyclophosphamide. Pharmacology and Therapeutics 1990 47 1 137 146 2-s2.0-0025336340 10.1016/0163-7258(90)90049-8 (Pubitemid 20183312)
26. Limper A. H., Chemotherapy-induced lung disease. Clinics in Chest Medicine 2004 25 1 53 64 2-s2.0-1542272637 10.1016/S0272-5231(03)00123-0 (Pubitemid 38296331)
27. Sulkowska M., Sulkowski S., Skrzydlewska E., Farbiszewski R., Cyclophosphamide-induced generation of reactive oxygen species. Comparison with morphological changes in type ii alveolar epithelial cells and lung capillaries. Experimental and Toxicologic Pathology 1998 50 3 209 220 2-s2.0-0031746914 (Pubitemid 28293903)
28. DeWys W. D., Goldin A., Mantel N., Hematopoietic recovery after large doses of cyclophosphamide: correlation of proliferative state with sensitivity. Cancer Research 1970 30 6 1692 1697 2-s2.0-0014806752
29. Kusano K., Ebara S., Tachibana K., Nishimura T., Sato S., Kuwaki T., Taniyama T., A potential therapeutic role for small nonpeptidyl compounds that mimic human granulocyte colony-stimulating factor. Blood 2004 103 3 836 842 2-s2.0-1642500419 10.1182/blood-2003-07-2307 (Pubitemid 38129540)